Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

The document concludes that various treatments for skin conditions are effective, but some require further research, and certain factors like gender and lifestyle can influence disease outcomes.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

There are several promising treatments for hair loss, including dutasteride, latanoprost, ketoconazole shampoo, anti-androgens, laser/light treatment, and platelet-rich plasma, but more research is needed.

5% minoxidil works better for hair growth than 1% minoxidil.

Certain patient characteristics can help predict hair regrowth success with ritlecitinib in alopecia areata.

Placental stem cell exosome therapy improves hair growth and reduces hair loss.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

Using platelet-rich plasma in hair restoration surgery significantly improves hair density after 6 months and is safe to use.

The IPL device is safe, effective, and has high patient satisfaction for hair removal.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Finasteride increased hair count and regrowth in men with hair loss but also caused more sexual side effects than placebo.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Injections with 0.5% minoxidil effectively treat female hair loss, increasing hair density and thickness.

The treatment combination is effective and generally safe for lung cancer.

Combining growth factors with minoxidil improves hair growth more than minoxidil alone.

Finasteride reduces prostate cancer risk by 30% without affecting Gleason scores.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

Bimatoprost 0.03% is as effective as minoxidil 2% for eyebrow growth.

Upadacitinib effectively treats severe alopecia areata and is safe.

Baricitinib significantly regrows hair in severe alopecia areata patients.

The trial aims to understand how obesity and lifestyle affect circadian rhythms in people with schizophrenia and bipolar disorder.

Progesterone initially worsens but later reduces neuropathic pain in mice, through different mechanisms.

Leontopodium alpinum extract may help reduce hair shedding by keeping hair in the growth phase longer.

Extracts improve hair growth in alopecia.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.

Mesotherapy is more effective than topical spray for female hair loss treatment.